Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Topics in Medicinal Chemistry is Scopus-indexed (Q4, CiteScore 1.4). Published by Springer Science and Business Media Deutschland GmbH.
Checked against the index lists dated .
ISSN 1862-2461Verify ISSN ↗1862-247XVerify ISSN ↗
Publisher: Springer Science and Business Media Deutschland GmbH
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Drug Discovery | 140 / 161 | 13th | Q4 |
| Molecular Medicine | 161 / 179 | 10th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2026 (also 2014–2024, 2009–2012), best quartile Q4, CiteScore 1.4.
Topics in Medicinal Chemistry is Q4 in Drug Discovery (rank 140 of 161) and Q4 in Molecular Medicine (rank 161 of 179), by CiteScore 2025.
Topics in Medicinal Chemistry is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.4, quartile Q4, 13th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric.
Topics in Medicinal Chemistry is published by Springer Science and Business Media Deutschland GmbH. Its print ISSN is 1862-2461 and its online ISSN is 1862-247X.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Topics in Medicinal Chemistry has an h-index of 21 and a 2-year mean of 0.32 citations per paper (OpenAlex). Its Scopus CiteScore is 1.4, quartile Q4. On 2-year citations it ranks #143 of 159 Scopus journals in Drug Discovery.
Topics in Medicinal Chemistry published 16 papers in 2024; its busiest recent year was 2019 with 62. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.